These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2385096)

  • 1. PDN-21: possible tumor marker for medullary thyroid carcinoma.
    Takami H; Shikata J; Horie H; Sekine K; Ito K
    J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
    Blind E; Raue F; Klaiber T; Zink A; Schroth J; Buhr H; Ziegler R
    J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.
    Schifter S
    Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
    Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
    Takami H
    Exp Clin Endocrinol; 1994; 102(5):370-3. PubMed ID: 7867699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
    Raue F; Blind E; Grauer A
    Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
    Takami H; Ito K
    Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
    Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
    Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmon and human calcitonin-like peptides in man.
    Tobler PH; Tschopp FA; Dambacher MA; Fischer JA
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):253-9. PubMed ID: 6723077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
    Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
    Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
    Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosecretion of calcitonin gene products: studies with a C18 cartridge extraction method for human plasma PDN-21 (katacalcin).
    Hurley DL; Katz HH; Tiegs RD; Calvo MS; Barta JR; Heath H
    J Clin Endocrinol Metab; 1988 Mar; 66(3):640-4. PubMed ID: 3350911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
    Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
    J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.
    Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L
    Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma.
    Lamb EJ; Heddle RM; Ellis A
    Postgrad Med J; 1999 May; 75(883):289-90. PubMed ID: 10533634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
    Carter WB; Taylor RL; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.